Mercedes Ferrer

Prof. Dr. Mercedes Ferrer


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Hypertension
Verified
Journal Article
Closed access
PDF file
JBJavier Blanco-Rivero
Javier Blanco-Rivero
VCVictoria Cachofeiro
Victoria Cachofeiro
VLVicente Lahera
Vicente Lahera
RARosa Aras-Lopez
Rosa Aras-Lopez
IMIvan Marquez-Rodas
Ivan Marquez-Rodas
GBGloria Balfagón
Gloria Balfagón
The aim of the present study was to analyze the possible involvement of vasoconstrictors prostanoids on the reduced endothelium-dependent relaxations produced by chronic administration of aldosterone in Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). For this purpose, acetylcholine (ACh) relaxations in aortic segments from both strains were analyzed in absence and presence of the cyclooxygenase-1 (COX-1) and COX-2 inhibitor indomethacin, the specific COX-2 inhibitor NS-398, the TP receptor antagonist (SQ 29 548), the thromboxane A 2 (TXA 2 ) synthase inhibitor furegrelate, and the prostacyclin (PGI 2 ) synthesis inhibitor tranylcypromine (TCP). In addition, COX-2 protein expression was studied by Western blot analysis. Release of prostaglandin E 2 (PGE 2 ) and the metabolites of PGF 2α , TXA 2 , and PGI 2 , 13,14-dihydro-15-keto PGF 2a , TXB 2 , and 6-keto-PGF 1α , respectively, were measured. Treatment with aldosterone did not modify blood pressure levels in any strain. However, aldosterone markedly reduced ( P <0.05) ACh-induced relaxations in segments from both strains in a similar extent. Indomethacin, NS-398, SQ 29 548, and TCP enhanced ( P <0.05) ACh relaxations in both strains treated with aldosterone. Aortic COX-2 protein expression was higher in both strains of rats treated with aldosterone. In normotensive animals, aldosterone increases the ACh-stimulated aortic production of 13,14-dihydro-15-keto PGF 2a, PGE 2 , and 6-keto-PGF 1α ( P <0.05). In SHR, ACh only increased the 6-keto-PGF 1α production ( P <0.05). It could be concluded that chronic treatment with aldosterone was able to produce endothelial dysfunction through COX-2 activation in normotensive and hypertensive conditions. PGI 2 seems to be the main factor accounting for endothelial dysfunction in hypertensive rats, whereas other prostanoids besides PGI 2 appear to be involved in endothelial dysfunction under normotensive conditions.

1 January 1996 in Journal of Vascular Research
Verified
Journal Article
Closed access
PDF file
MFMercedes Ferrer
Mercedes Ferrer
MMMarjorie Meyer
Marjorie Meyer
GOGeorge Osol
George Osol
The purpose of the present study was to determine whether estrogen replacement in ovariectomized rats could modulate arterial diameter responses to β-adrenoceptor activation. Under relaxed conditions (0.1 mM papaverine) there were no differences in the lumen diameter of isolated, pressurized (50 mm Hg) mesenteric arteries from nontreated (191.7 ± 13.8 µm; n = 19) versus those from estrogen-treated (190.1 ± 11 µm; n = 14) ovariectomized Sprague-Dawley rats. In arteries precontracted with noradrenaline (0.3-1 µM), isoprenaline (0.01–10 µM)-induced relaxation was significantly increased in arteries from ovariectomized estrogen-treated rats (52.4 ± 2% of the maximal relaxation induced by 0.1 mM papaverine, vs. 33.3 ± 6.5%; p < 0.01). The half-maximal concentration value was 0.04 ± 0.05 µM in estrogen-treated rats and 0.4 ± 0.1 µM in nontreated rats (p < 0.01). This response was inhibited by propranolol (1 µM) in both groups to a comparable extent (61.5%), and was unaffected by endothelial removal. Forskolin (0.01–10 µM) induced similar concentration-dependent vasodilation in arteries of both groups of rats with no differences in sensitivity or maximal response. These results suggest that isoprenaline acts through β-adrenoceptors present on vascular smooth muscle and that estrogen replacement enhances the relaxant responses induced by β-adrenoceptor activation by an endothelium-independent mechanism.

19 March 2005 in Nitric Oxide
Verified
Journal Article
Closed access
MMMa del Carmen Martín
Ma del Carmen Martín
GBGloria Balfagón
Gloria Balfagón
NMNuria Minoves
Nuria Minoves
JBJavier Blanco-Rivero
Javier Blanco-Rivero
MFMercedes Ferrer
Mercedes Ferrer

5 November 2007 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
AMAina Martorell
Aina Martorell
JBJavier Blanco-Rivero
Javier Blanco-Rivero
RARosa Aras-LÓPez
Rosa Aras-LÓPez
ASAna Sagredo
Ana Sagredo
GBGloria BalfagÓN
Gloria BalfagÓN
MFMercedes Ferrer
Mercedes Ferrer
This study examines the effect of endogenous male sex hormones on thromboxane A2 (TXA2), prostaglandin (PG) I2, PGF2α, and PGE2 release, as well as their role in acetylcholine (ACh)-mediated relaxation in the aorta. Aortic segments from orchidectomized and control male Sprague–Dawley rats were used to measure COX-2 protein expression. ACh-induced relaxation of these segments was also determined in the absence and presence of the COX-2 inhibitor NS-398, the TXA2 synthesis inhibitor furegrelate, the PGI2 synthesis inhibitor tranylcypromine (TCP), or the thromboxane-prostanoid (TP) receptor antagonist SQ-29 548. Furthermore, TXA2, PGI2, PGF2α, and PGE2 release as well as the vasomotor effect of exogenous TXA2, PGI2, PGF2α, and PGE2 were measured. COX-2 expression was increased in aortas from orchidectomized rats. NS-398 did not modify the ACh-induced relaxation in arteries from both control or orchidectomized rats. Furegrelate did not modify the ACh-induced relaxation in aortas from control animals but, in aortas from orchidectomized rats, it increased that response. TCP decreased the ACh-induced relaxation in both groups. The TP receptor antagonist, SQ29 548 failed to modify ACh-induced relaxation in aortas from either rat group. Pre-incubating arteries from orchidectomized rats with TCP plus furegrelate did not modify the decrease in the ACh response induced by TCP alone, but this response was restored by co-incubation of TCP plus SQ29 548. ACh-induced TXA2, PGI2, PGF2α, and PGE2 release were increased by orchidectomy. The presence of furegrelate plus TCP increased the ACh-induced PGE2 release more in arteries from orchidectomized than in those from control rats. The contractile responses induced by the TXA2 mimetic U-46619 or by exogenous PGF2α were similar in arteries from control and orchidectomized rats, while those induced by exogenous PGE2 were increased in arteries from orchidectomized rats; the vasodilator response induced by exogenous PGI2 was decreased in arteries from orchidectomized rats. These data show that endogenous male sex hormone deprivation increases COX-2 expression, the release of TXA2, PGI2, PGF2α, and PGE2 and the contractile response induced by exogenous PGE2 and TXA2, while it decreases the relaxation induced by exogenous PGI2. Despite the predominance of vasoconstrictor prostanoids derived from COX-2 in aortas from orchidectomized rats, the ACh-induced relaxation remains increased.

1 March 2017 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MPMercedes Perusquía
Mercedes Perusquía
NHNieves Herrera
Nieves Herrera
MFMercedes Ferrer
Mercedes Ferrer
JSJohn N. Stallone
John N. Stallone

1 July 1999 in General Pharmacology: The Vascular System
Verified
Journal Article
Closed access
MFMercedes Ferrer
Mercedes Ferrer
JMJ. Marı́n
J. Marı́n
AEA. Encabo
A. Encabo
MAM.J. Alonso
M.J. Alonso
GBG. Balfagón
G. Balfagón